Cancer Genetics Inc (CGIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CGIX | ICLR | CRL | PRAH | NVCR |
| Company | Cancer Genetics Inc | Icon Plc | Charles River Laboratories Intl | Pra Health | Novocure Ltd Ord Sh |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 4.67 | 299.18 | 207.58 | 167.73 | 17.78 |
| High | 4.69 | 303.16 | 208.03 | 168.76 | 17.78 |
| Low | 4.30 | 294.52 | 203.32 | 164.28 | 17.16 |
| Last | 4.61 | 303.07 | 205.79 | 165.21 | 17.45 |
| Change | -0.11 | +2.15 | -3.83 | -2.80 | -0.39 |
| % Change | -2.33% | +0.71% | -1.83% | -1.67% | -2.19% |
| Volume | 612,400 | 1,013,600 | 1,173,000 | 13,411,000 | 1,173,600 |
| 20-Day Average Volume | 1,143,545 | 654,675 | 619,985 | 1,559,430 | 1,022,585 |
| Previous Close | 4.72 | 300.92 | 209.62 | 168.01 | 17.84 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.79 | 306.75 | 198.31 | 168.38 | 17.85 |
| 20-Day Raw Stochastic | 9.75% | 57.34% | 71.46% | 13.70% | 32.76% |
| 20-Day Relative Strength | 44.49% | 45.92% | 51.46% | 44.32% | 46.91% |
| Weighted Alpha | -13.14 | +15.39 | -2.00 | +71.79 | -5.69 |
| Today's Opinion | 56% Buy | 40% Sell | 80% Sell | 40% Buy | 8% Sell |
| Previous Opinion | 56% Buy | 24% Sell | 80% Sell | 40% Buy | 8% Buy |
| Last Month's Opinion | 96% Buy | 72% Buy | 88% Sell | 80% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.78% since 03/23/21 | +1.02% since 09/13/24 | +3.62% since 09/13/24 | -0.81% since 06/23/21 | -6.03% since 09/13/24 |
| Low | 4.30 on 03/30/21 | 292.37 on 09/17/24 | 199.31 on 09/16/24 | 164.28 on 06/30/21 | 17.16 on 09/20/24 |
| High | 7.25 on 03/25/21 | 310.54 on 09/19/24 | 213.61 on 09/19/24 | 170.82 on 06/28/21 | 18.86 on 09/17/24 |
| 1-Month | |||||
| %Chg | -29.19% since 02/26/21 | -6.46% since 08/20/24 | +1.62% since 08/20/24 | -3.34% since 05/28/21 | -0.29% since 08/20/24 |
| Low | 4.30 on 03/30/21 | 269.08 on 09/10/24 | 186.21 on 09/10/24 | 164.28 on 06/30/21 | 16.10 on 09/03/24 |
| High | 7.48 on 03/22/21 | 328.35 on 08/26/24 | 213.61 on 09/19/24 | 172.43 on 06/01/21 | 20.21 on 08/30/24 |
| 3-Month | |||||
| %Chg | +70.11% since 12/28/20 | -4.09% since 06/20/24 | -1.83% since 06/20/24 | +7.45% since 03/30/21 | -9.00% since 06/20/24 |
| Low | 2.61 on 12/29/20 | 269.08 on 09/10/24 | 186.21 on 09/10/24 | 151.77 on 04/01/21 | 15.85 on 07/08/24 |
| High | 17.50 on 02/10/21 | 347.72 on 07/16/24 | 254.15 on 08/01/24 | 175.95 on 05/25/21 | 23.87 on 07/30/24 |
| 6-Month | |||||
| %Chg | +11.89% since 09/28/20 | -9.73% since 03/20/24 | -23.26% since 03/20/24 | +33.13% since 12/30/20 | +28.03% since 03/20/24 |
| Low | 2.11 on 10/30/20 | 269.08 on 09/10/24 | 186.21 on 09/10/24 | 119.90 on 02/08/21 | 11.70 on 04/23/24 |
| High | 17.50 on 02/10/21 | 347.72 on 07/16/24 | 274.77 on 03/22/24 | 175.95 on 05/25/21 | 24.74 on 05/20/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,833 | 24,824,398 | 10,797,524 | 10,704,781 | 1,919,780 |
| Shares Outstanding, K | 4,085 | 82,495 | 51,510 | 64,795 | 107,611 |
| Annual Sales | 7,310,000 | 8,120,180,000 | 4,129,410,000 | 3,183,370,000 | 509,340,000 |
| Annual Net Income | -6,710,000 | 612,340,000 | 474,620,000 | 197,040,000 | -207,040,000 |
| Last Quarter Sales | 1,570,000 | 2,120,160,000 | 1,026,120,000 | 933,780,000 | 150,360,000 |
| Last Quarter Net Income | -1,350,000 | 146,910,000 | 94,080,000 | 56,940,000 | -33,380,000 |
| 60-Month Beta | 2.72 | 1.22 | 1.36 | 1.33 | 0.71 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.75 on 07/24/24 | 2.80 on 08/07/24 | 1.35 on 04/28/21 | -0.31 on 07/25/24 |
| Latest Earnings Date | 11/18/20 | 10/23/24 | 11/13/24 | 08/05/21 | 10/24/24 |
| Most Recent Dividend | N/A | N/A | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | N/A | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.42 | 20.11 | 38.71 | 0.00 |